首頁 > 市場調查報告書 > 醫療設備

整形外科

市場調查報告書

商品編碼

2042712

全球肱三頭肌植入市場：按產品類型和最終用戶分析 - 市場規模、產業動態、機會分析和預測（2026-2035 年）

Global Triceps Implants Market: Analysis By Product Type, End User - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035

出版日期: 2026年05月05日 | 出版商:

Astute Analytica | 英文 220 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球肱三頭肌植入市場正經歷穩定且結構性成長，這主要得益於人們日益增強的美學意識和對重組手術解決方案不斷成長的需求。 2025年，該市場規模約為6.2845億美元，預計到2035年將達到約9.7596億美元。這意味著在2026年至2035年的預測期內，該市場將以約4.50%的複合年成長率成長，顯示在臨床需求和美容需求的雙重驅動下，市場正穩步擴張。

推動這一成長的主要因素是全球對整形美容手術日益成長的興趣。在健身文化盛行、社群媒體影響以及人們對自身形像日益關注的背景下，越來越多的人尋求透過手術來改善肌肉輪廓和對稱性。雖然肱三頭肌植入在整個整形外科市場中屬於小眾領域，但它也受益於這一趨勢，因為當運動和減脂等傳統方法效果不佳時，越來越多的患者尋求針對性的解決方案來改善上臂輪廓。

顯著的市場趨勢

全球肱三頭肌植入市場呈現高度集中的寡占結構，其主導地位並非由大型整形外科集團構成，而是由專注於美容和塑形植入植入的專業製造商所主導。這種細分市場定位反映了該市場的獨特性質，它處於重組手術和選擇性美容手術的交匯點，需要兼具手術精準性、解剖學設計專業知識和最佳美容效果。

Implantech Associates 被公認為該領域的全球領導者。其在北美的市場地位尤為突出，估計佔了約 60% 的肱三頭肌植入市場。在歐洲，Sebbin 已成為領先的美容植入製造商，其產品包括與肱三頭肌植入物相關的先進塑形解決方案。 Polytech Health & Aesthetics 在德語區（德國、奧地利和瑞士）擁有強大的市場地位，該地區對高品質的美容和重組植入有著穩固的需求。

關鍵成長要素

翻修手術市場正成為全球肱三頭肌植入市場的重要成長要素，預計將佔整體市場擴張的約15%。與初次植入手術不同，翻修手術旨在糾正併發症、改善美觀效果或更換不再符合功能或解剖學預期的舊植入。這個細分市場反映了市場的成熟度，許多曾接受過手術的患者現在尋求翻修手術。

新機會的趨勢

全球肱三頭肌植入市場目前正經歷重大的結構性變革，從傳統的「一刀切」式標準植入模型轉向由3D建模和患者特異性設計技術驅動的更先進、高度個人化的系統。這一轉變反映了整形外科和整形外科領域更廣泛的變革，在這些領域，精準性、解剖結構匹配和最佳化的功能效果在手術計劃和植入選擇中變得越來越重要。

最佳化障礙

價格仍是進入全球肱三頭肌植入市場的主要障礙，不同地區的市場價格趨勢差異顯著。亞洲和拉丁美洲的價格彈性較高，因此需求對術費變動較為敏感，而美國的價格彈性相對較低。這主要歸功於美國強大的購買力、重組手術的保險覆蓋以及完善的擇期手術資金籌措體系，這些因素減輕了價格波動對患者需求的影響。平均而言，外科醫生費用約為 5,500 美元，這反映了精準解剖增強和肌腱重組所需的專業技術。手術中心費用約為 2,500 美元，涵蓋了使用認證手術中心、手術室基礎設施和術後恢復支援等費用。麻醉服務費用通常約為每次手術 1,200 美元，具體費用取決於手術時間和臨床複雜程度。

市場動態和趨勢
- 成長要素
- 抑制因子
- 機會
- 主要趨勢
市場規模及預測，2020-2035年
- 依產品類型
  - 關鍵見解
    - 標準三頭植入
    - 訂製三頭植入
    - 模組化三頭植入
    - 三頭植入重新置換
- 最終用戶
  - 關鍵見解
    - 醫院
    - 整形外科診所
    - 門診手術中心
- 按地區
  - 關鍵見解
    - 北美洲
      - 美國
      - 加拿大
      - 墨西哥
    - 歐洲
      - 西歐
        
        英國
        德國
        法國
        義大利
        西班牙
        其他西歐國家
      - 東歐
        
        波蘭
        俄羅斯
        其他東歐國家
    - 亞太地區
      - 中國
      - 印度
      - 日本
      - 韓國
      - 澳洲和紐西蘭
      - ASEAN
        
        柬埔寨
        印尼
        馬來西亞
        菲律賓
        新加坡
        泰國
        越南
        其他東南亞國協
      - 其他亞太國家
    - 中東和非洲
      - UAE
      - 沙烏地阿拉伯
      - 南非
      - 其他中東和非洲國家
    - 南美洲
      - 阿根廷
      - 巴西
      - 其他南美國家

第6章：北美市場分析

第7章：歐洲市場分析

第8章：亞太市場分析

第9章：中東和非洲市場分析

第10章：南美市場分析

第11章：公司簡介

Acumed LLC
Arthrex, Inc.
B. Braun Melsungen AG
BioTek Instruments, Inc.
CONMED Corporation
DJO Global, Inc.
Exactech, Inc.
Globus Medical, Inc.
Johnson & Johnson
Medtronic plc
Orthofix Medical Inc.
Smith & Nephew plc
Stryker Corporation
Zimmer Biomet Holdings, Inc.
Other Prominent Players

第12章附錄

簡介目錄

Product Code: AA05261783

The global triceps implants market is experiencing steady and structurally supported growth, reflecting a combination of rising aesthetic consciousness and increasing demand for reconstructive surgical solutions. In 2025, the market was valued at approximately US$ 628.45 million, and it is projected to reach around US$ 975.96 million by 2035. This represents a compound annual growth rate (CAGR) of about 4.50% during the forecast period from 2026 to 2035, indicating consistent expansion driven by both clinical necessity and elective cosmetic demand.

A key factor contributing to this growth is the increasing global interest in aesthetic body contouring procedures. As fitness culture, social media influence, and body image awareness continue to rise, more individuals are seeking surgical enhancements to achieve improved muscular definition and symmetry. Triceps implants, although a niche segment within the broader aesthetic surgery market, are benefiting from this trend as patients look for targeted solutions to enhance upper arm contouring when traditional methods such as exercise or fat reduction are insufficient.

Noteworthy Market Developments

The global triceps implants market is characterized by a highly concentrated oligopolistic structure that is dominated not by large orthopedic conglomerates, but by specialized aesthetic and body-contouring implant manufacturers. This niche positioning reflects the unique nature of the market, which sits at the intersection of reconstructive surgery and elective aesthetic enhancement, requiring a combination of surgical precision, anatomical design expertise, and cosmetic outcome optimization.

Implantech Associates is widely regarded as the undisputed global leader in this segment. The company's dominance is particularly pronounced in North America, where it is estimated to command approximately 60% of the regional triceps implant market. In Europe, Sebbin holds a prominent position as a leading manufacturer of aesthetic medical implants, including advanced body contouring solutions relevant to the triceps implant segment. Polytech Health & Aesthetics maintains a strong foothold in the DACH region, covering Germany, Austria, and Switzerland, where demand for high-quality aesthetic and reconstructive implants is well established.

Core Growth Drivers

The revision economy has emerged as a significant growth driver in the global triceps implants market, contributing an estimated 15% of overall market expansion. Unlike primary implant procedures, revision surgeries are performed to correct complications, improve aesthetic outcomes, or replace earlier-generation implants that no longer meet functional or anatomical expectations. This segment reflects the maturation of the market, where an increasing number of patients who underwent earlier procedures are now seeking corrective interventions.

Emerging Opportunity Trends

The global triceps implants market is currently undergoing a significant structural transition, moving away from a traditional "one-size-fits-all" standard implant model toward a more advanced, highly personalized system driven by 3D modeling and patient-specific design technologies. This shift reflects broader changes in orthopedic and aesthetic surgery, where precision, anatomical compatibility, and optimized functional outcomes are becoming increasingly important in surgical planning and implant selection.

Barriers to Optimization

Pricing remains the primary barrier to entry in the global triceps implants market, with affordability dynamics varying sharply across regions. The market exhibits high price elasticity in Asia and Latin America, where demand is more sensitive to changes in procedure cost, but it is comparatively inelastic in the United States, where stronger purchasing power, insurance coverage for reconstructive cases, and a well-developed elective surgery financing ecosystem reduce the impact of price fluctuations on patient demand. On average, the surgeon's fee accounts for approximately USD 5,500, reflecting the expertise required for precise anatomical augmentation or tendon reconstruction. Facility fees contribute an additional USD 2,500, covering the use of accredited surgical centers, operating room infrastructure, and post-operative recovery support. Anesthesia services typically add around USD 1,200 per procedure, depending on duration and clinical complexity.

Detailed Market Segmentation

Based on product type, standard triceps implants accounted for approximately 46.7% of total market revenue in 2025, underscoring an important operational and logistical dynamic within the triceps implants industry. The continued dominance of standard, off-the-shelf implant systems reflects the need for speed, availability, and procedural efficiency, particularly in high-volume surgical environments where patient throughput and scheduling flexibility are critical performance factors.

By end users, hospitals accounted for approximately 58.2% of the global triceps implants market share, highlighting a clear structural distinction between medically necessary orthopedic interventions and elective aesthetic procedures. This dominance is primarily driven by the clinical urgency and complexity associated with traumatic and degenerative injuries of the triceps tendon, particularly distal triceps tendon ruptures, which fall under reconstructive orthopedic care rather than cosmetic enhancement.

Segment Breakdown

By Product Type

Standard Triceps Implants
Custom Triceps Implants
Modular Triceps Implants
Revision Triceps Implants

By End User

Hospitals
Orthopedic Clinics
Ambulatory Surgical Centers

By Region

North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
South Korea
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
Saudi Arabia
South Africa
UAE
Rest of MEA
South America
Argentina
Brazil
Rest of South America

Geography Breakdown

North America accounted for approximately 43% of the global triceps implant market revenue in 2025, a dominance that is primarily rooted in pricing power rather than proportional procedural volume. The region, particularly the United States, operates within a "high-ticket" healthcare ecosystem where surgical procedures command significantly higher reimbursement rates and out-of-pocket costs compared to most other global markets. This pricing structure substantially inflates the recorded market value, meaning that revenue contribution is disproportionately high even when the number of procedures is more closely aligned with global demand distribution.
Another key structural factor supporting North America's revenue dominance is the specialized nature of its surgical workforce. Unlike many other regions where general plastic surgeons perform a broad range of aesthetic procedures, the United States has developed a dense network of "body-only" or body-contouring specialists who focus extensively on limb augmentation and sculpting procedures. These highly specialized surgeons often perform large procedural volumes, sometimes exceeding 50 triceps augmentation cases annually, which contributes to consistent and repeatable demand for advanced implant systems.
Leading Market Participants
DJO Global, Inc.
BioTek Instruments, Inc.
Arthrex, Inc.
Acumed LLC
Exactech, Inc.
Medtronic plc
Johnson & Johnson
Stryker Corporation
Globus Medical, Inc.
Orthofix Medical Inc.
Braun Melsungen AG
Smith & Nephew plc
CONMED Corporation
Zimmer Biomet Holdings, Inc.
Other Prominent Players

Table of Content

Chapter 1. Executive Summary: Global Triceps Implants Market

Chapter 2. Research Methodology & Research Framework

2.1. Research Objective
2.2. Product Overview
2.3. Market Segmentation
2.4. Qualitative Research
- 2.4.1. Primary & Secondary Sources
2.5. Quantitative Research
- 2.5.1. Primary & Secondary Sources
2.6. Breakdown of Primary Research Respondents, By Region
2.7. Assumption for Study
2.8. Market Size Estimation
2.9. Data Triangulation

Chapter 3. Global Triceps Implants Market Overview

3.1. Industry Value Chain Analysis
- 3.1.1. Raw Material Suppliers (Medical-grade Silicone Elastomer, ePTFE, Titanium)
- 3.1.2. Implant Design & 3D Modeling/CAD Service Providers
- 3.1.3. Implant Manufacturers (Standard, Custom, Modular, Revision)
- 3.1.4. Sterilization, Quality Assurance & Regulatory Service Providers
- 3.1.5. Distributors, Sales Representatives & Medical Device Wholesalers
- 3.1.6. Healthcare Providers (Plastic Surgeons, Orthopedic Surgeons, Hospitals, ASCs)
- 3.1.7. End Patients (Aesthetic, Reconstructive, Trauma & Sports Medicine)
3.2. Industry Outlook
- 3.2.1. Overview of the Global Aesthetic & Reconstructive Surgery Industry
- 3.2.2. Regulatory Landscape (FDA Class II, EU MDR 2017/745, Custom Device Exemption)
3.3. PESTLE Analysis
3.4. Porter's Five Forces Analysis
- 3.4.1. Bargaining Power of Suppliers
- 3.4.2. Bargaining Power of Buyers
- 3.4.3. Threat of Substitutes
- 3.4.4. Threat of New Entrants
- 3.4.5. Degree of Competition
3.5. Market Growth and Outlook
- 3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
- 3.5.2. Price Trend Analysis, By Product Type

Chapter 4. Global Triceps Implants Market Analysis

4.1. Competition Dashboard
- 4.1.1. Market Concentration Rate
- 4.1.2. Company Market Share Analysis (Value %), 2025
- 4.1.3. Competitor Mapping & Benchmarking

Chapter 5. Global Triceps Implants Market Analysis

5.1. Market Dynamics and Trends
- 5.1.1. Growth Drivers
- 5.1.2. Restraints
- 5.1.3. Opportunity
- 5.1.4. Key Trends
5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 5.2.1. By Product Type
  - 5.2.1.1. Key Insights
    - 5.2.1.1.1. Standard Triceps Implants
    - 5.2.1.1.2. Custom Triceps Implants
    - 5.2.1.1.3. Modular Triceps Implants
    - 5.2.1.1.4. Revision Triceps Implants
- 5.2.2. By End User
  - 5.2.2.1. Key Insights
    - 5.2.2.1.1. Hospitals
    - 5.2.2.1.2. Orthopedic Clinics
    - 5.2.2.1.3. Ambulatory Surgical Centers
- 5.2.3. By Region
  - 5.2.3.1. Key Insights
    - 5.2.3.1.1. North America
      - 5.2.3.1.1.1. The U.S.
      - 5.2.3.1.1.2. Canada
      - 5.2.3.1.1.3. Mexico
    - 5.2.3.1.2. Europe
      - 5.2.3.1.2.1. Western Europe
        
        5.2.3.1.2.1.1. The UK
        5.2.3.1.2.1.2. Germany
        5.2.3.1.2.1.3. France
        5.2.3.1.2.1.4. Italy
        5.2.3.1.2.1.5. Spain
        5.2.3.1.2.1.6. Rest of Western Europe
      - 5.2.3.1.2.2. Eastern Europe
        
        5.2.3.1.2.2.1. Poland
        5.2.3.1.2.2.2. Russia
        5.2.3.1.2.2.3. Rest of Eastern Europe
    - 5.2.3.1.3. Asia Pacific
      - 5.2.3.1.3.1. China
      - 5.2.3.1.3.2. India
      - 5.2.3.1.3.3. Japan
      - 5.2.3.1.3.4. South Korea
      - 5.2.3.1.3.5. Australia & New Zealand
      - 5.2.3.1.3.6. ASEAN
        
        5.2.3.1.3.6.1. Cambodia
        5.2.3.1.3.6.2. Indonesia
        5.2.3.1.3.6.3. Malaysia
        5.2.3.1.3.6.4. Philippines
        5.2.3.1.3.6.5. Singapore
        5.2.3.1.3.6.6. Thailand
        5.2.3.1.3.6.7. Vietnam
        5.2.3.1.3.6.8. Rest of ASEAN
      - 5.2.3.1.3.7. Rest of Asia Pacific
    - 5.2.3.1.4. Middle East & Africa
      - 5.2.3.1.4.1. UAE
      - 5.2.3.1.4.2. Saudi Arabia
      - 5.2.3.1.4.3. South Africa
      - 5.2.3.1.4.4. Rest of MEA
    - 5.2.3.1.5. South America
      - 5.2.3.1.5.1. Argentina
      - 5.2.3.1.5.2. Brazil
      - 5.2.3.1.5.3. Rest of South America

Chapter 6. North America Market Analysis

6.1. Market Dynamics and Trends
- 6.1.1. Growth Drivers
- 6.1.2. Restraints
- 6.1.3. Opportunity
- 6.1.4. Key Trends
6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 6.2.1. Key Insights
  - 6.2.1.1. By Product Type
  - 6.2.1.2. By End User
  - 6.2.1.3. By Country

Chapter 7. Europe Market Analysis

7.1. Market Dynamics and Trends
- 7.1.1. Growth Drivers
- 7.1.2. Restraints
- 7.1.3. Opportunity
- 7.1.4. Key Trends
7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 7.2.1. Key Insights
  - 7.2.1.1. By Product Type
  - 7.2.1.2. By End User
  - 7.2.1.3. By Country

Chapter 8. Asia Pacific Market Analysis

8.1. Market Dynamics and Trends
- 8.1.1. Growth Drivers
- 8.1.2. Restraints
- 8.1.3. Opportunity
- 8.1.4. Key Trends
8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 8.2.1. Key Insights
  - 8.2.1.1. By Product Type
  - 8.2.1.2. By End User
  - 8.2.1.3. By Country

Chapter 9. Middle East & Africa Market Analysis

9.1. Market Dynamics and Trends
- 9.1.1. Growth Drivers
- 9.1.2. Restraints
- 9.1.3. Opportunity
- 9.1.4. Key Trends
9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 9.2.1. Key Insights
  - 9.2.1.1. By Product Type
  - 9.2.1.2. By End User
  - 9.2.1.3. By Country

Chapter 10. South America Market Analysis

10.1. Market Dynamics and Trends
- 10.1.1. Growth Drivers
- 10.1.2. Restraints
- 10.1.3. Opportunity
- 10.1.4. Key Trends
10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 10.2.1. Key Insights
  - 10.2.1.1. By Product Type
  - 10.2.1.2. By End User
  - 10.2.1.3. By Country